Proper Name: Botulism Immune Globulin Intravenous (Human)
Manufacturer: California Department of Public Health
- Treatment of infant botulism caused by type A or type B in patients below one year of age.
- Dear Healthcare Provider Letter: IMPORTANT CHANGE IN BabyBIG PRESCRIBING INFORMATION - ARCHIVED
Date: September 23, 2013
- FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.